Journal
FRONTIERS IN ENDOCRINOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2022.1065856
Keywords
microvascular complications; diabetic retinopathy; diabetic nephropathy; biomarkers; therapy; artificial intelligence
Categories
Funding
- National Natural Science Foundation of China [82170854, 81870579, 81870545, 81570715, 81170736]
- National High Level Hospital Clinical Research Funding [2022-PUMCH-C-019]
Ask authors/readers for more resources
This paper reviews the recent advancements in novel biomarkers, artificial intelligence technology, therapeutic agents, and approaches for diabetic retinopathy and nephropathy, providing valuable insights into the management of microvascular complications.
The global burden due to microvascular complications in patients with diabetes mellitus persists and even increases alarmingly, the intervention and management are now encountering many difficulties and challenges. This paper reviews the recent advancement and progress in novel biomarkers, artificial intelligence technology, therapeutic agents and approaches of diabetic retinopathy and nephropathy, providing more insights into the management of microvascular complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
